H. Lundbeck A/S HLUYY
Set alert
As of Apr 24, 3:47 PM ET
52-week range unavailable
- Open
- 24.00
- Prev close
- 22.00
- Mkt cap
- 0
- Vol
- 7.54K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 22.00
- High
- 22.00
News
1 year ago defenseworld.net
H. Lundbeck A/S (OTCMKTS:HLUYY) & FIH Mobile (OTCMKTS:FXCNY) Financial Survey
Dividends H. Lundbeck A/S pays an annual dividend of $0.20 per share and has a dividend yield of 0.9%. FIH Mobile pays an annual dividend of $0.06 per share and has a dividend yield of 0.3%. H.…
1 year ago seekingalpha.com
Lundbeck's Appreciation Potential Is Closely Tied To A High-Risk Clinical Pipeline (Rating Upgrade)
H. Lundbeck A/S faces significant patent cliffs and a risky pipeline, but management's expense restructuring and Longboard acquisition can drive future growth. The $2.5B acquisition of Longboard…
2 years ago marketwatch.com
Longboard Pharmaceuticals' stock soars amid Lundbeck's $2.6 billion deal to acquire the company
H. Lundbeck plans to acquire Longboard Pharmaceuticals in a $2.6 billion deal, the companies announced Monday.
2 years ago seekingalpha.com
Lundbeck On A Better Path, But With Some Risks
Lundbeck's new CEO has laid out a plan to maximize the value of the company's current portfolio, reorganize R&D, and deploy capital towards growth-sustaining M&A. The company aims to maximize the…
3 years ago businesswire.com
Lundbeck to Present Broad Range of Data on Migraine and Brain Health at 75th Annual Meeting of the American Academy of Neurology
DEERFIELD, Ill.--(BUSINESS WIRE)--Lundbeck to Present Broad Range of Data on Migraine and Brain Health at 75th Annual Meeting of the American Academy of Neurology
4 years ago businesswire.com
Otsuka Pharmaceutical and Lundbeck to Present Phase 3 Data for Brexpiprazole in Patients with Alzheimer's Dementia at AAIC 2022
PRINCETON, N.J. & DEERFIELD, Ill.--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc., and H. Lundbeck A/S (Lundbeck) today announce that new Phase 3 data for brexpiprazole…
4 years ago zacks.com
H Lundbeck AS (HLUYY) Surges 12.5%: Is This an Indication of Further Gains?
H Lundbeck AS (HLUYY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price…
4 years ago seekingalpha.com
H. Lundbeck A/S (HLUKF) CEO Deborah Dunsire on Q4 2021 Results - Earnings Call Transcript
H. Lundbeck A/S (HLUKF) CEO Deborah Dunsire on Q4 2021 Results - Earnings Call Transcript
4 years ago seekingalpha.com
H. Lundbeck A/S (HLUKF) CEO Deborah Dunsire on Q3 2021 Results - Earnings Call Transcript
H. Lundbeck A/S (HLUKF) CEO Deborah Dunsire on Q3 2021 Results - Earnings Call Transcript
5 years ago seekingalpha.com
H. Lundbeck A/S (HLUKF) CEO Deborah Dunsire on Q2 2021 Results - Earnings Call Transcript
H. Lundbeck A/S (HLUKF) CEO Deborah Dunsire on Q2 2021 Results - Earnings Call Transcript
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Tuesday
-
7 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
Stocks That Hit 52-Week Lows On Tuesday
-
7 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Monday
-
7 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Thursday